[Objectivization of the pharmacodynamic effect of a new parasympatholytic using gastric pressure readings and clinical experiments under double-blind conditions].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001774:Blood Chemical Analysis; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004361:Drug Tolerance; D004415:Dyspepsia / Q000188:drug therapy*; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007082:Ileum / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics; D011312:Pressure; D011759:Pyrrolidines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D013270:Stomach / Q000187:drug effects*
D010276:Parasympatholytics; D011759:Pyrrolidines
Obiettivazione dell'effetto farmacodinamico di un nuovo parasimpaticolitico mediante gastro-tensiografia e sperimentazione clinia in condizioni di doppia cecità.